Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $14.5M invested in Ovid Therapeutics in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
67% less capital invested
Capital invested by funds: $44.4M → $14.5M (-$29.9M)
Holders
82
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$384K | |
| 2 | +$286K | |
| 3 | +$208K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$153K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$112K |
Top Sellers
| 1 | -$2.66M | |
| 2 | -$881K | |
| 3 | -$392K | |
| 4 |
MCM
Monimus Capital Management
Woodbridge,
New Jersey
|
-$129K |
| 5 |
JPMorgan Chase & Co
New York
|
-$65.4K |
